Tsarfaty I - Search Results

1

Alteration of Met protooncogene product expression and prognosis in breast carcinomas.

Tsarfaty I, Alvord WG, Resau JH, Altstock RT, Lidereau R, Bieche I, Bertrand F, Horev J, Klabansky RL, Keydar I, Vande Woude GF. Tsarfaty I, et al. Anal Quant Cytol Histol. 1999 Oct;21(5):397-408. Anal Quant Cytol Histol. 1999. PMID: 10560522

2

Met-HGF/SF mediates growth arrest and differentiation in T47D breast cancer cells.

Ronen D, Altstock RT, Firon M, Mittelman L, Sobe T, Resau JH, Vande Woude GF, Tsarfaty I. Ronen D, et al. Among authors: tsarfaty i. Cell Growth Differ. 1999 Feb;10(2):131-40. Cell Growth Differ. 1999. PMID: 10074906

3

Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells.

Firon M, Shaharabany M, Altstock RT, Horev J, Abramovici A, Resau JH, Vande Woude GF, Tsarfaty I. Firon M, et al. Among authors: tsarfaty i. Oncogene. 2000 May 11;19(20):2386-97. doi: 10.1038/sj.onc.1203557. Oncogene. 2000. PMID: 10828880

4

Algorithms for quantitation of protein expression variation in normal versus tumor tissue as a prognostic factor in cancer: Met oncogene expression, and breast cancer as a model.

Altstock RT, Stein GY, Resau JH, Tsarfaty I. Altstock RT, et al. Among authors: tsarfaty i. Cytometry. 2000 Nov 1;41(3):155-65. Cytometry. 2000. PMID: 11042611

5

Met kinetic signature derived from the response to HGF/SF in a cellular model predicts breast cancer patient survival.

Stein GY, Yosef N, Reichman H, Horev J, Laser-Azogui A, Berens A, Resau J, Ruppin E, Sharan R, Tsarfaty I. Stein GY, et al. Among authors: tsarfaty i. PLoS One. 2012;7(9):e45969. doi: 10.1371/journal.pone.0045969. Epub 2012 Sep 25. PLoS One. 2012. PMID: 23049908 Free PMC article.

6

Human endogenous retrovirus (HERV-K) reverse transcriptase as a breast cancer prognostic marker.

Golan M, Hizi A, Resau JH, Yaal-Hahoshen N, Reichman H, Keydar I, Tsarfaty I. Golan M, et al. Among authors: tsarfaty i. Neoplasia. 2008 Jun;10(6):521-33. doi: 10.1593/neo.07986. Neoplasia. 2008. PMID: 18516289 Free PMC article.

7

The met proto-oncogene receptor and lumen formation.

Tsarfaty I, Resau JH, Rulong S, Keydar I, Faletto DL, Vande Woude GF. Tsarfaty I, et al. Science. 1992 Aug 28;257(5074):1258-61. doi: 10.1126/science.1387731. Science. 1992. PMID: 1387731

8

Expression of genes coding for pS2, c-erbB2, estrogen receptor and the H23 breast tumor-associated antigen. A comparative analysis in breast cancer.

Zaretsky JZ, Weiss M, Tsarfaty I, Hareuveni M, Wreschner DH, Keydar I. Zaretsky JZ, et al. Among authors: tsarfaty i. FEBS Lett. 1990 Jun 4;265(1-2):46-50. doi: 10.1016/0014-5793(90)80880-r. FEBS Lett. 1990. PMID: 2194831 Free article.

9

In situ activation pattern of Met docking site following renal injury and hypertrophy.

Dekel B, Biton S, Yerushalmi GM, Altstock RT, Mittelman L, Faletto D, Smordinski NI, Tsarfaty I. Dekel B, et al. Among authors: tsarfaty i. Nephrol Dial Transplant. 2003 Aug;18(8):1493-504. doi: 10.1093/ndt/gfg215. Nephrol Dial Transplant. 2003. PMID: 12897086

10

Grappling with metastatic risk: bringing molecular imaging of Met expression toward clinical use.

Hay R, Cao B, Tsarfaty I, Tsarfaty G, Resau J, Vande Woude G. Hay R, et al. Among authors: tsarfaty i, tsarfaty g. J Cell Biochem Suppl. 2002;39:184-93. doi: 10.1002/jcb.10441. J Cell Biochem Suppl. 2002. PMID: 12552618 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters